Robotic assisted surgery (RAS) was perceived as the rising star of the minimally invasive surgery (MIS) since its early stages but, its penetration into the general use of surgery was very slow at the beginning. Over the first two decades of its existence, RAS struggled to be accepted as a valid alternative for standard MIS. Despite the promoted benefits offered by the computerassisted telemanipulation, the main limitations were related to the financial burden of the technology, while the real advantages over "classic" laparoscopy were modest. While medical institutions were not happy to support a wider use of RAS, a question related to the surgical expertise and indirectly to the better patients outcomes was raised. Is RAS improving the skills of an average surgeon to be as good as the MIS experts and reaching a higher level for her/his surgical outcomes? As the answer is very complex, and it is related to so many factors, the debate was always marked by many controverses and no conclusions. Often, during those times, an enthusiastic surgeon attracted by robotic technology, happened to be invited to get trained more for laparoscopic skills, rather than encouraged to spending resources for inconsistent benefits for the patients. Moreover, one could often hear during the surgical conferences arrogant quotes such as â??a fool with a tool is still a foolâ? (Grady Booch).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.21614/chirurgia.2836 | DOI Listing |
Front Antibiot
March 2024
Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Antimicrobial resistance in bacteria has been associated with significant morbidity and mortality in hospitalized patients. In the era of big data and of the consequent frequent need for large study populations, manual collection of data for research studies on antimicrobial resistance and antibiotic use has become extremely time-consuming and sometimes impossible to be accomplished by overwhelmed healthcare personnel. In this review, we discuss relevant concepts pertaining to the automated extraction of antibiotic resistance and antibiotic prescription data from laboratory information systems and electronic health records to be used in clinical studies, starting from the currently available literature on the topic.
View Article and Find Full Text PDFInt J Urol
January 2025
Department of Nephrology and Urology, Japanese Red Cross Fukui Hospital, Fukui, Japan.
JSLS
January 2025
Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ. (Dr. Fong).
Despite evidence indicating patient and hospital benefits of minimally invasive surgery (MIS) over open surgery, there is still access barriers to MIS. Availability of training and associated learning curve, health literacy, and hospital characteristics (location, size) have been identified as the primary barriers to the adoption of MIS. Robotic assisted surgery could help to overcome some of these barriers and increase access to MIS through easier tele-mentoring and potential for remote access.
View Article and Find Full Text PDFBMJ Open
January 2025
Institute of Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
Background: Magnetic resonance-guided transurethral ultrasound ablation (MR-TULSA) is a new focal therapy for treating localised prostate cancer that is associated with fewer adverse effects (AEs) compared with established treatments. To support large-scale clinical implementation, information about cost-effectiveness is required.
Objective: To evaluate the cost-utility of MR-TULSA compared with robot-assisted radical prostatectomy (RARP), external beam radiation therapy (EBRT) and active surveillance (AS) for patients with low- to favourable intermediate-risk localised prostate cancer.
J Clin Orthod
October 2024
Editor-in-Chief, Journal of Clinical Orthodontics, Greenwood Village, CO.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!